| 标题 |
 Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials |
| 网址 | |
| DOI | |
| 其它 |
期刊：Lancet 作者：Hauser SL, Giovannoni G, Montalban X, Oh J, Bar-Or A, Sormani MP, Weber MS, Stoll S, Nicholas JA, Nehrych T, Bonek R, Selmaj K, Maciejowski M, Zecevic D, Raposo C, Owen R, Bonati U, Madjar K, Harfst E, Wang Q, Raievska A, Manfrini M, Schneble HM, Kappos L, MUSETTE and GAVOTTE Study Groups 出版日期：2026-05-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
Copyright
OK
yanyanmi
雪海
愉快的真
大力的冬萱
zhaiyiying
TSUKIMI
lieaait
有点奔
Oracle
cx
学霸业
嘻嘻哈哈
咖啡豆
Nole
哈桑
潇洒的惋清
Criminology34
皖公网安备34019202002308
